Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Targeting MerTK decreases efferocytosis and increases anti-tumor immune infiltrate in prostate cancer.

Autor: Myers Chen, Kayla V., de Groot, Amber E., Mendez, Sabrina A., Mallin, Mikaela M., Amend, Sarah R., Pienta, Kenneth J.

Publikováno v: Medical Oncology; Oct2023, Vol. 40 Issue 10, p1-12, 12p

Cells in the Polyaneuploid Cancer Cell State are Pro-Metastatic.

Autor: Mallin MM; Cancer Ecology Center, James Buchanan Brady Urological Institute, Johns Hopkins Medical Institute, Baltimore, MD, USA.; Cellular and Molecular Medicine Graduate Training Program, Johns Hopkins School of Medicine, Baltimore, MD, USA., Rolle LTA; Cancer Ecology Center, James Buchanan Brady Urological Institute, Johns Hopkins Medical Institute, Baltimore, MD, USA., Schmidt MJ; Convergent Science Institute in Cancer, Michelson Center for Convergent Bioscience, Dornsife College of Letters, Arts and Sciences, University of Southern California, Los Angeles, CA, USA., Nair SP; Cancer Ecology Center, James Buchanan Brady Urological Institute, Johns Hopkins Medical Institute, Baltimore, MD, USA., Zurita AJ; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kuhn P; Convergent Science Institute in Cancer, Michelson Center for Convergent Bioscience, Dornsife College of Letters, Arts and Sciences, University of Southern California, Los Angeles, CA, USA.; Department of Biological Sciences, Dornsife College of Letters, Arts, and Sciences, University of Southern California, Los Angeles, CA, USA.; Department of Biomedical Engineering, Viterbi School of Engineering, University of Southern California, Los Angeles, CA, USA.; Department of Aerospace and Mechanical Engineering, Viterbi School of Engineering, University of Southern California, Los Angeles, CA, USA.; Institute of Urology, Catherine & Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.; Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA., Hicks J; Convergent Science Institute in Cancer, Michelson Center for Convergent Bioscience, Dornsife College of Letters, Arts and Sciences, University of Southern California, Los Angeles, CA, USA.; Department of Biological Sciences, Dornsife College of Letters, Arts, and Sciences, University of Southern California, Los Angeles, CA, USA.; Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA., Pienta KJ; Cancer Ecology Center, James Buchanan Brady Urological Institute, Johns Hopkins Medical Institute, Baltimore, MD, USA.; Cellular and Molecular Medicine Graduate Training Program, Johns Hopkins School of Medicine, Baltimore, MD, USA., Amend SR; Cancer Ecology Center, James Buchanan Brady Urological Institute, Johns Hopkins Medical Institute, Baltimore, MD, USA.; Cellular and Molecular Medicine Graduate Training Program, Johns Hopkins School of Medicine, Baltimore, MD, USA.

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2024 Jul 16. Date of Electronic Publication: 2024 Jul 16.

Twelve unanswered questions in cancer inspired by the life and work of Leland Chung: "if this is true, what does it imply"?

Autor: Li M; The Brady Urological Institute, Johns Hopkins Medical Institutions Baltimore, MD 21287, USA., Gonye AL; The Brady Urological Institute, Johns Hopkins Medical Institutions Baltimore, MD 21287, USA., Truskowski K; The Brady Urological Institute, Johns Hopkins Medical Institutions Baltimore, MD 21287, USA., Loftus LV; The Brady Urological Institute, Johns Hopkins Medical Institutions Baltimore, MD 21287, USA., Urbanski LA; The Brady Urological Institute, Johns Hopkins Medical Institutions Baltimore, MD 21287, USA., Myers KV; The Brady Urological Institute, Johns Hopkins Medical Institutions Baltimore, MD 21287, USA., Mallin MM; The Brady Urological Institute, Johns Hopkins Medical Institutions Baltimore, MD 21287, USA., Yang ME; The Brady Urological Institute, Johns Hopkins Medical Institutions Baltimore, MD 21287, USA., Mendez SA; The Brady Urological Institute, Johns Hopkins Medical Institutions Baltimore, MD 21287, USA., Kostecka LG; The Brady Urological Institute, Johns Hopkins Medical Institutions Baltimore, MD 21287, USA., Udedibor CR; The Brady Urological Institute, Johns Hopkins Medical Institutions Baltimore, MD 21287, USA., Kim CJ; The Brady Urological Institute, Johns Hopkins Medical Institutions Baltimore, MD 21287, USA., Kuczler MD; The Brady Urological Institute, Johns Hopkins Medical Institutions Baltimore, MD 21287, USA., Shin GH; The Brady Urological Institute, Johns Hopkins Medical Institutions Baltimore, MD 21287, USA., Amend SR; The Brady Urological Institute, Johns Hopkins Medical Institutions Baltimore, MD 21287, USA., Pienta KJ; The Brady Urological Institute, Johns Hopkins Medical Institutions Baltimore, MD 21287, USA.

Publikováno v: American journal of clinical and experimental urology [Am J Clin Exp Urol] 2021 Aug 25; Vol. 9 (4), pp. 254-260. Date of Electronic Publication: 2021 Aug 25 (Print Publication: 2021).